ASTRO Names Richard Hoppe President-Elect

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 12
Volume 4
Issue 12

MIAMI BEACH--Richard Hoppe, MD, has been named president-elect of the American Society for Therapeutic Radiology and Oncology (ASTRO). Dr. Hoppe is chairman of the Department of Radiation Oncology at Stanford University School of Medicine. He will take office at the Society's annual meeting to be held in Los Angeles next October.

MIAMI BEACH--Richard Hoppe, MD, has been named president-electof the American Society for Therapeutic Radiology and Oncology(ASTRO). Dr. Hoppe is chairman of the Department of RadiationOncology at Stanford University School of Medicine. He will takeoffice at the Society's annual meeting to be held in Los Angelesnext October.

The current president, who took office at this year's ASTRO meeting,is Steven A. Leibel, MD, vice-chairman, clinical director, andEnid A. Haupt Chair, Department of Radiation Oncology, MemorialSloan-Kettering Cancer Center.

Other new officers announced at the meeting are: chairman of theboard, Jay R. Harris, MD, Joint Center for Radiation Therapy,Harvard Medical School; secretary, Karen K. Fu, MD, Universityof California, San Francisco, Mt. Zion Cancer Center; and treasurer,John D. Earle, MD, Mayo Medical School.

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content